There are 2789 resources available
1055P - Prognostic relevance of tumor-infiltrating lymphocytes in early-stage melanoma
Presenter: Eftychia Chatziioannou
Session: ePoster Display
1056P - Survival of patients with advanced melanoma according to first-line treatment and key prognostic factors: Real-world data from GEM1801 study
Presenter: Ivan Marquez-Rodas
Session: ePoster Display
1057P - ROS1 mutation can serve- as a potential efficacious predictor of immunotherapy in melanoma patients
Presenter: Hucheng Liu
Session: ePoster Display
955P - Prognostic factor analysis of atezolizumab-bevacizumab in unresectable hepatocellular carcinoma: Korean cancer study group (KCSG) study
Presenter: Jaekyung Cheon
Session: ePoster Display
956P - A multi-analyte liquid biopsy assay integrating cfDNA methylation and protein biomarkers for liver cancer diagnosis
Presenter: Dezhen Guo
Session: ePoster Display
966P - Diabetes therapy burden as proxy of impairment of immune checkpoint inhibitors efficacy
Presenter: Alessio Cortellini
Session: ePoster Display
967P - The time of anti-PD-1 infusion improves survival outcomes by fasting conditions simulation in non-small cell lung cancer
Presenter: Anna Vilalta
Session: ePoster Display
968P - Association between use of antibiotics (ATB) and clinical outcomes with tislelizumab (tisle) monotherapy
Presenter: Zheng-Gang Ren
Session: ePoster Display
969P - Effect of angiotensin II inhibition on non-small cell lung cancer response to immune checkpoint blockers
Presenter: Patricia Pereira
Session: ePoster Display
970P - Assessment of anti-PD-1 antibody and immune complex binding to Fcγ receptors and clinical implications
Presenter: Elena Daveri
Session: ePoster Display